Acepodia, a biotechnology company developing cancer immunotherapies based on its novel Antibody-Cell Conjugation (ACC) and off-the-shelf NK (oNK) technology today announced it will participate in the …
( read original story …)
The Taiwan NEWS
Acepodia, a biotechnology company developing cancer immunotherapies based on its novel Antibody-Cell Conjugation (ACC) and off-the-shelf NK (oNK) technology today announced it will participate in the …
( read original story …)